T

Turning Point Therapeutics

150 employees

Turning Point Therapeutics is a pharmaceutical company that discovers and develops precision medicines for cancer and other diseases.

Basic info

Industry

biotechnology research

Sectors

ALK

Biotechnology

oncogenic

SRC

MASC

Oncology

Drug resistance

G2032R

Precision medicine

metastasis

G1202R

NTRK

JAK2

ROS1

NTRK1

NTRK2

NSCLC

NTRK3

Pharmaceutical

FAK

Health Care

fusion gene

Structure-based design

Therapeutics

Date founded

2013

Funding rounds raised

Total raised

$80M

from 13 investors over 13 rounds

T

Turning Point Therapeutics raised $80M on October 19, 2018

Investors: Lilly Asia Ventures, Nextech Invest, Kenson Ventures, Foresite Capital, venBio Partners, S.R. One Ltd and OrbiMed Advisors

T

Turning Point Therapeutics raised $45M on May 23, 2017

Investors: Lilly Asia Ventures, OrbiMed Advisors, S.R. One Ltd and SV Tech Ventures

T

Turning Point Therapeutics raised $18M on March 21, 2016

Investors: CRCM Ventures

T

Turning Point Therapeutics raised undisclosed on July 28, 2015